High expression levels of MYC, CEBPD and HK2 are significantly associated with low hsa‐miR‐429 expression levels, and these expression patterns predict poor outcomes in UBUC and UTUC patients. Here, MYC is linked to renal pelvis/ureter urothelial carcinoma.